Arecor Therapeutics (LON:AREC) Trading Up 1.8%

Arecor Therapeutics plc (LON:ARECGet Free Report) shot up 1.8% on Tuesday . The company traded as high as GBX 150 ($1.88) and last traded at GBX 142.50 ($1.79). 31,740 shares were traded during mid-day trading, an increase of 223% from the average session volume of 9,824 shares. The stock had previously closed at GBX 140 ($1.76).

Arecor Therapeutics Stock Performance

The stock has a market cap of £43.65 million, a P/E ratio of -459.68 and a beta of -0.22. The company has a quick ratio of 6.24, a current ratio of 2.52 and a debt-to-equity ratio of 1.26. The business has a 50 day moving average price of GBX 148.75 and a two-hundred day moving average price of GBX 172.39.

About Arecor Therapeutics

(Get Free Report)

Arecor Therapeutics plc, a biopharmaceutical company, focuses on developing products in diabetes and other indications. The company through its proprietary formulation technology platform, Arestat, developing a portfolio of proprietary products in diabetes and other indications, as well as working with pharmaceutical and biotechnology companies to deliver enhanced reformulations of therapeutic products.

Further Reading

Receive News & Ratings for Arecor Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Arecor Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.